These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 16119691

  • 1. The occurrence of pulmonary hypertension in patients with systemic sclerosis hospitalized in the Department of Rheumatology and Internal Diseases Medical University of Białystok in years 2003-2004.
    Gińdzieńska-Sieśkiewicz E, Kowal-Bielecka O, Kita J, Lisowska A, Domysławska I, Musiał W, Sierakowski S.
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():297-300. PubMed ID: 16119691
    [Abstract] [Full Text] [Related]

  • 2. [Causes of death of patients with systemic sclerosis].
    Chwieśko S, Sierakowski S, Kowal-Bielecka O.
    Pol Merkur Lekarski; 2006 Oct; 21(124):341-4. PubMed ID: 17205772
    [Abstract] [Full Text] [Related]

  • 3. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis.
    Kampolis C, Plastiras S, Vlachoyiannopoulos P, Moyssakis I, Tzelepis G.
    Scand J Rheumatol; 2008 Oct; 37(4):278-83. PubMed ID: 18612928
    [Abstract] [Full Text] [Related]

  • 4. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
    Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, Mouthon L, Hatron PY, Jego P, Allanore Y, Tiev KP, Agard C, Cosnes A, Cirstea D, Constans J, Farge D, Viallard JF, Harle JR, Patat F, Imbert B, Kahan A, Cabane J, Clerson P, Guillevin L, Humbert M, Itinér AIR-Sclérodermie Study Group.
    Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D, Mouthon L, Hachulla E, Pagnoux C, de Groote P, Remy-Jardin M, Matran R, Lambert M, Queyrel V, Morell-Dubois S, Guillevin L, Hatron PY.
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma.
    Chang B, Schachna L, White B, Wigley FM, Wise RA.
    J Rheumatol; 2006 Feb; 33(2):269-74. PubMed ID: 16465657
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study.
    Vonk MC, Broers B, Heijdra YF, Ton E, Snijder R, van Dijk AP, van Laar JM, Bootsma H, van Hal PT, van den Hoogen FH, van Daele PL.
    Ann Rheum Dis; 2009 Jun; 68(6):961-5. PubMed ID: 18511546
    [Abstract] [Full Text] [Related]

  • 10. The relationship of dyspnoea to function and quality of life in systemic sclerosis.
    Baron M, Sutton E, Hudson M, Thombs B, Markland J, Pope J, Robinson D, Jones N, Docherty P, Abu-Hakima M, LeClercq S, Smith D, Mathieu JP.
    Ann Rheum Dis; 2008 May; 67(5):644-50. PubMed ID: 17728334
    [Abstract] [Full Text] [Related]

  • 11. Determinants of pulmonary arterial hypertension in scleroderma.
    Plastiras SC, Karadimitrakis SP, Kampolis C, Moutsopoulos HM, Tzelepis GE.
    Semin Arthritis Rheum; 2007 Jun; 36(6):392-6. PubMed ID: 17204309
    [Abstract] [Full Text] [Related]

  • 12. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
    Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, Desai A, Seibold JR.
    J Rheumatol; 2008 Mar; 35(3):458-65. PubMed ID: 18203320
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
    Callejas-Rubio JL, Moreno-Escobar E, de la Fuente PM, Pérez LL, Fernández RR, Sánchez-Cano D, Mora JP, Ortego-Centeno N.
    J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
    [Abstract] [Full Text] [Related]

  • 15. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
    Hofstee HM, Vonk Noordegraaf A, Voskuyl AE, Dijkmans BA, Postmus PE, Smulders YM, Serné EH.
    Ann Rheum Dis; 2009 Feb; 68(2):191-5. PubMed ID: 18375538
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of pulmonary hypertension in systemic sclerosis.
    de Azevedo AB, Sampaio-Barros PD, Torres RM, Moreira C.
    Clin Exp Rheumatol; 2005 Feb; 23(4):447-54. PubMed ID: 16095111
    [Abstract] [Full Text] [Related]

  • 17. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG.
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [Abstract] [Full Text] [Related]

  • 18. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis.
    Bredemeier M, Xavier RM, Capobianco KG, Restelli VG, Rohde LE, Pinotti AF, Pitrez EH, Vieira MV, Fontoura MA, Ludwig DH, Brenol JC.
    J Rheumatol; 2004 Feb; 31(2):286-94. PubMed ID: 14760798
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.